Related Experiment Video
Updated: Apr 8, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Thioflavin T templates amyloid β(1-40) conformation and aggregation pathway
Maria Giovanna Di Carlo1, Velia Minicozzi2, Vito Foderà3
1Dipartimento di Fisica e Chimica, Università degli Studi di Palermo, Via Archirafi 36, I-90123 Palermo, Italy.
Abstract:
Aβ(1-40) peptide supramolecular assembly and fibril formation processes are widely recognized to have direct implications in the progression of Alzheimer's disease. The molecular basis of this biological process is still unknown and there is a strong need of developing effective strategies to control the occurring events. To this purpose the exploitation of small molecules interacting with Aβ aggregation represents one of the possible routes. Moreover, the use specific labeling has represented so far one of the most common and effective methods to investigate such a process. This possibility in turn rests on the reliability of the probe/labels involved. Here we present evidences of the effect of Thioflavin T (ThT), a worldwide used fluorescent dye to monitor amyloid growth, on the Aβ(1-40) conformation, stability and aggregation. By combining experimental information and Molecular Dynamics simulation results, we show that the presence of ThT in solution affects peptide conformation inducing peculiar supramolecular association. In particular ThT interactions with specific Aβ(1-40) residues promote a rigid partially-folded conformation which shifts the balance between different species in solution toward a more aggregation-prone ensemble of peptides, leading to aggregation. Our findings suggest ways for developing strategies to reverse and block aggregation or to stimulate supramolecular assembly and consequently reduce the presence of transient oligomers. This investigation underlines the need of developing label-free techniques for unbiased quantitative studies of Aβ(1-40) aggregation processes.
Insights
The fluorescent dye Thioflavin T (ThT), commonly used to study Alzheimer's disease (AD) progression, unexpectedly accelerates Aβ(1-40) peptide aggregation. This highlights the need for label-free methods for accurate amyloid studies.
Area of Science:
- Biochemistry
- Neuroscience
- Molecular Biology
Background:
- Alzheimer's disease (AD) is linked to amyloid-beta (Aβ) peptide aggregation.
- Understanding Aβ(1-40) assembly is crucial for developing AD therapies.
- Fluorescent probes like Thioflavin T (ThT) are widely used to monitor amyloid formation.
Purpose of the Study:
- To investigate the impact of Thioflavin T (ThT) on Aβ(1-40) conformation, stability, and aggregation.
- To elucidate the molecular mechanisms by which ThT influences Aβ(1-40) self-assembly.
- To assess the reliability of ThT as a probe in amyloid research.
Main Methods:
- Experimental techniques combined with Molecular Dynamics (MD) simulations.
- Analysis of Aβ(1-40) peptide conformation and stability in the presence of ThT.
- Investigating ThT-induced changes in supramolecular assembly and aggregation pathways.
Main Results:
- Thioflavin T (ThT) alters Aβ(1-40) peptide conformation, inducing a rigid, partially-folded state.
- ThT promotes specific supramolecular associations that enhance aggregation propensity.
- The presence of ThT shifts the equilibrium towards aggregation-prone peptide species.
Conclusions:
- ThT is not an inert probe and can artifactually accelerate Aβ(1-40) aggregation.
- Findings suggest strategies to control or block Aβ aggregation by manipulating peptide conformation.
- Emphasizes the critical need for label-free techniques for unbiased studies of Aβ aggregation.
More Related Videos
10:04Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
Published on: October 20, 2017
08:25Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
Published on: April 19, 2021
Related Concept Videos
Amyloid Fibrils
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...